BARCELONA, Spain, March 2, 2026 /PRNewswire/ -- vivo today offered a first look at its upcoming top-tier imaging flagship, ...
CANBERA (dpa-AFX) - The U.S. dollar strengthened against other major currencies in the European session on Monday, as investors closely monitored escalating West Asian tensions. The conflict in the ...
HTX, a leading global cryptocurrency exchange, has announced the listing of BTW (Bitway) on March 2. BTW/USDT spot trading is now available to ...
Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a Canadian developer of high-grade flake graphite deposits ...
DeepSig, a pioneer in AI-native wireless communications, announces its role as a founding member of the OCUDU Ecosystem Foundation, a new collaboration initiative launched under the Linux Foundation ...
Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today ...
Dataswans today announced a formal dual mission that unites data-driven marketing services with certified digital education under one integrated ...
LUND, SE / ACCESS Newswire / March 2, 2026 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today comments on the announcement by Shanghai Henlius Biotech, Inc. that the first patient has been dosed in ...
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its next generation ...
European stocks were deep in the red on Monday as a broadening Middle East conflict dented investors' appetite for riskier assets. Inflation worries returned ...
Enabling growth and supporting value creation for RWS RWS (RWS.L), a global AI solutions company, today announces the appointment of Stephen Lamb as Chief Financial Officer and Director. With more ...
1h
VERAXA Biotech Shareholders Approve Merger and Issuance of New Shares to Voyager Acquisition Corp.
VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies, today announced that its shareholders approved the merger between VERAXA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results